Abstract:Interleukin-11 (IL-11) is a multifunctional cytokine possessing wide biological activities which can affect growth differentiation in several hematopoietic cell types, including early pluripotent stem cells, megakaryocyte progenitors and megakaryocytes, erythrocyte progenitors, etc. [1]. It is also identified as inhibiting adipogenesis in preadipocyces and stimulating production of several acute phase plasma proteins in hepatocytes. IL11 has been shown to share many biological activities with IL-6, including the ability to activate expression of the same early response genes. Until now, the 3D-structure of IL-11 has not been available from experiments, although large studies have been performed. From previous studies, it has been revealed that the cytokine family shares a common structural motif consisting of four anti-parallel helices in an up-up-down-down configuration. To date, the four-helix bundle fold has been observed in human growth hormone (HGH), interleukin-2 (IL-2), interleukin-4 (IL-4), granulocytecolony-stimulating factor (G-CSF), inter-leukin-5 (IL5) and human macrophage colony-stimulating factor (GM-CSF). The cytokine family is one of the most diverse protein families but their structural relationships can be determined by comparing their amino acid sequences. From sequence alignment, it can be found that only G-CSF shares sequence similarity higher than 30% with IL11. In this paper, we have combined sequence comparison and secondary structural prediction to generate a molecular model of interleukin11. The X-ray structure of GCSF [2] was used as a template to produce the model, moreover, in the sequence alignment, the information from the secondary structural prediction of the GOR_II method [3] was taken into account. The validation of the model suggests that the quality of this structure is sound. The predicted model may aid in the design of experiments to better understand IL11 and its interaction with receptors.

Preparation of Functional Monoclonal Antibody Against Human IL-11 and Analysis of Its Biological Characteristics

Preparation and characterization of a novel monoclonal antibody against human PD-1

Microsoft Word-Yuan et al PDF

Generation and Characterization of Four Novel Monoclonal Antibodies Against Human Programmed Death-1 Molecule.

Preparation and characterization of a specific monoclonal antibody against a new gene product: URG11.

Preparation and Characterization of Monoclonal Antibody Against M.hyorhinis

Production and Identification of Monoclonal Antibodies to Chcd25

Humoral Immune Responses Induced By Anti-Idiotypic Antibody Fusion Protein Of 6b11scfv/Hgm-Csf In Balb/C Mice

Preparation,Characterization and Application of Monoclonal Antibodies to Recombinant Human Interferon—α2a

Production and Characterization of Monoclonal Antibody to Duck IL-2

Preparation and Identification of Monoclonal Antibodies Against Humanin

Prepartion and Identification of the Monoclonal Antibody to CTGF

Expression and Purification of Recombinant Human Interleukin-11 in Pichia Pastoris

[Cdna Cloning, Fusion Expression in Escherichia Coli and Activity Assay of Hil-11].

Optimization of in Vitro Immunization Protocol to Produce Antigen Specific Human Monoclonal Antibody by Demonstrating the Role of IL-10

Preparation of a novel monoclonal antibody against active components of PHA-L from Phaseolus vulgaris and its functional characteristics

Preparation of Anti-human CTLA-4 Monoclonal Antibody and Study on Their Biological Activities

Molecular modeling of the three-dimensional structure of the human interleukin-11

Development of a cell-based qualitative assay for detection of neutralizing anti-human interleukin-1 receptor antagonist (hIL-1Ra) antibodies in rats.

[Eukaryotic Expression of Human IL17-RD-ECD and Generation of Its Monoclonal Antibody].

ESTABLISHMENT OF FOUR HYBRIDOMA CELL LINES SECRETING ANTI-HUMAN IGA MCABS